BeiGene Ltd-ADR (BGNE), Kurser og Nyheter

Handle

BeiGene Ltd-ADR-kurs

12.16% Forrige uke

Markedsverdi

19.21B

Dagens område

204.24

214.17

52U-område

126.81

214.17

Volum (3M)

269.09K

Pris-inntjeningsforhold

-38.95

Inntekt

3.1B

Siste nytt om BeiGene Ltd-ADR

Se alt

BeiGene Ltd. Employees Buy Shares Under Company PlanTipRankscirka 5 timer siden

BeiGene Launches Employee Stock Purchase OfferingTipRanks4 dager siden

BeiGene Announces New Share Option GrantsTipRanks7 dager siden

Festet innlegg

@Cancer-Med

Storbritannia

10 dager siden

European patients begin receiving world’s first lung cancer vaccine in 'revolutionary' new trial. 👉 A lung cancer patient in the UK has become one of the first to participate in a groundbreaking trial for the world's first vaccine against the disease. Lung cancer is the leading cause of... Vis flere Oversett

Diskusjoner om Topp

@Salim_B

Frankrike

23 dager siden

🚧🚧🚧 Focus sur les Sociétés Disruptives et Innovantes en Biotechnologies Médicales L’industrie des biotechnologies médicales connaît une transformation rapide, portée par des avancées scientifiques révolutionnaires. Que ce soit l’édition génétique, les thérapies à base d’ARNm ou les innovations en... Vis flere Oversett

Interesting

100.00%

Neutral

100.00%

Boring

100.00%

Follow for more content

100.00%

@ChinaTech

Storbritannia

cirka en måned siden

Dear Investors, Here is your monthly update for July 2024 ✨ July 2024 was a month filled with news that impacted markets in various ways. Volatility was evident as global investors shifted from big tech to small-cap stocks. The Japanese yen appreciated significantly after the Bank of Japan raised... Vis flere Oversett

@crh_55

Storbritannia

5 måneder siden

𝗗𝗮𝗶𝗹𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 / 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗥𝗲𝗰𝗮𝗽 🇺🇸 Tuesday, 23/4/2024 On Tuesday, equity markets saw gains driven by a focus on corporate earnings and economic growth prospects. The $SPX500 experienced broad-based sector leadership, particularly in communication services and technology, reflecting... Vis flere Oversett

@crh_55

Storbritannia

5 måneder siden

𝗗𝗮𝗶𝗹𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 / 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗥𝗲𝗰𝗮𝗽 🇺🇸 Thursday, 11/4/2024 Following a near 1% drop in the $SPX500 on Wednesday, fuelled by higher-than-expected consumer price index (CPI) inflation, markets rebounded on Thursday. This uptick was spurred by a producer price index (PPI) for March... Vis flere Oversett

@A_Capital

Storbritannia

6 måneder siden

The worst-performing large-cap stocks from the past week include: - LI Auto $LI (Li Auto Inc-ADR) declined by 19.3%. - MicroStrategy $MSTR (MicroStrategy Incorporated) fell by 14.6%. - Lululemon $LULU (Lululemon Athletica Inc) dropped by 13.3%. - BeiGene $BGNE (BeiGene Ltd-ADR) decreased by 10.6%. -... Vis flere Oversett

@A_Capital

Storbritannia

6 måneder siden

The large-cap stocks that experienced the poorest performance during the previous week. LI Auto $LI (Li Auto Inc-ADR) -19.3%🔴 MicroStrategy $MSTR (MicroStrategy Incorporated) -14.6%🔴 Lululemon $LULU (Lululemon Athletica Inc) -13.3%🔴 BeiGene $BGNE (BeiGene Ltd-ADR) -10.6%🔴 Accenture $ACN (Accenture... Vis flere Oversett

@crh_55

Storbritannia

6 måneder siden

Redigert

𝗗𝗮𝗶𝗹𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 / 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗥𝗲𝗰𝗮𝗽 🇺🇸 Following Thursday's record-breaking close, stock markets paused yesterday, witnessing declines in both the $DJ30 and the $RTY . However, the $NSDQ100 continued its upward trend for the fifth consecutive session, buoyed by strong performances... Vis flere Oversett

@crh_55

Storbritannia

6 måneder siden

𝗗𝗮𝗶𝗹𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 / 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗥𝗲𝗰𝗮𝗽 🇺🇸 Following a Tuesday rally, the U.S. stock market ended Wednesday on an uneven note. The $DJ30 experienced a slight increase, in contrast to the $NSDQ100, which is known for its concentration of tech stocks, and saw a decrease. Investors are... Vis flere Oversett

@bennetgaissmai71

Tyskland

6 måneder siden

Whats going on with $BGNE (BeiGene Ltd-ADR)? Oversett

BGNE

BeiGene Ltd-ADR

208.68

10.99 (5.56%)

Handle

@crh_55

Storbritannia

6 måneder siden

𝗗𝗮𝗶𝗹𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 / 𝗣𝗼𝗿𝘁𝗳𝗼𝗹𝗶𝗼 𝗥𝗲𝗰𝗮𝗽 🇺🇸 On Thursday, U.S. stocks experienced an uptick, buoyed by a slew of positive economic indicators, including fresh inflation data. Additionally, reports suggesting lawmakers had reached an agreement to extend funding deadlines and avert a government... Vis flere Oversett

Om BeiGene Ltd-ADR

BeiGene Ltd er et kinesisk biofarmasiselskap, som forsker på, utvikler og markedsfører medisiner og behandlinger mot forskjellige kreftformer. Flere av selskapets medisiner er på markedet i Kina og andre land. BeiGene Ltd har også både kontorer og klinisk testing i land utenfor Kina. Selskapet ble grunnlagt i 2010. BeiGene Ltd har hovedkontoret sitt i Beijing. BeiGene Ltd utvikler medisiner basert på immunterapi og andre avanserte modeller, som retter seg direkte mot de gener og proteiner som står bak kreft. BeiGene Ltd-aksjen handles med aksjesymbolet BGNE på NASDAQ GS. Legg til selskapet i overvåkningslisten, og motta nyheter og oppdateringer om selskapets aksjekurs og videre utvikling på eToro.

John V. Oyler, MBA

CEO

10K

Ansatte

2010

Grunnlagt

Hovedkontor